Beneficial Effect of TGFβ Antagonism in Treating Diabetic Nephropathy Depends on When Treatment Is Started

Publisher： Karger

E-ISSN： 1660-2129|104|4|e158-e168

ISSN： 1660-2129

Source： Nephron Experimental Nephrology, Vol.104, Iss.4, 2006-08, pp. : e158-e168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Renal TGF-β System in the db/db Mouse Model of Diabetic Nephropathy

By  

Nephron Experimental Nephrology, Vol. 6, Iss. 3, 1998-05 ,pp. : 226-233

Karger

Access to resources Recommend Favorite

Reducing Serum Uric Acid Attenuates TGF-β1-Induced Profibrogenic Progression in Type 2 Diabetic Nephropathy

By  

Nephron Experimental Nephrology, Vol. 121, Iss. 3-4, 2013-01 ,pp. : e109-e121

Karger

Access to resources Recommend Favorite

Amelioration of Established Diabetic Nephropathy by Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in db/db Mice

By  

Nephron Experimental Nephrology, Vol. 105, Iss. 2, 2006-11 ,pp. : e45-e52

Karger

Access to resources Recommend Favorite

Urinary Oxidative Stress Markers Closely Reflect the Efficacy of Candesartan Treatment for Diabetic Nephropathy

By  

Nephron Experimental Nephrology, Vol. 111, Iss. 1, 2008-12 ,pp. : e20-e30

Karger

Access to resources Recommend Favorite

Differential Effects of Transient Treatment of Spontaneously Hypertensive Rats with Various Antihypertensive Agents on the Subsequent Development of Diabetic Nephropathy

By  

Nephron Experimental Nephrology, Vol. 109, Iss. 1, 2008-05 ,pp. : e20-e28

Karger

Access to resources Recommend Favorite